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Effects of Lead and Mercury on the Blood Proteome of Children
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Heavy metal exposure in children has been associated with a variety of physiological and neurological
problems. The goal of this study was to utilize proteomics to enhance the understanding of biochemical
interactions responsible for the health problems related to lead and mercury exposure at concentrations
well below CDC guidelines. Blood plasma and serum samples from 34 children were depleted of their
most abundant proteins using antibody-based affinity columns and analyzed using two different
methods, LC-MS/MS and 2-D electrophoresis coupled with MALDI-TOF/MS and tandem mass
spectrometry. Apolipoprotein E demonstrated an inverse significant association with lead concentrations
(average being one microgram/deciliter) as deduced from LC-MS/MS and 2-D electrophoresis and
confirmed by Western blot analysis. This coincides with prior findings that Apolipoprotein E genotype
moderates neurobehavioral effects in individuals exposed to lead. Fifteen other proteins were identified
by LC-MS/MS as proteins of interest exhibiting expressional differences in the presence of environ-
mental lead and mercury.
Keywords: proteomics • children, blood • cardiovascular • lead • mercury • apolipoprotein E • Pb • Hg
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Introduction
Lead (Pb) and mercury (Hg) are well-known toxicants, and
their impact is assessed and monitored by different bodies of
the World Health Organization.1-3 Pb negatively affects the
human central nervous system,4 kidney,5 liver,6 and cardio-
vascular system.7 Children are known to be particularly sensi-
tive to Pb exposure.8-10 The negative effects of Pb have been
documented at concentrations significantly below 10 µg/dL,
which is considered by the Centers for Disease Control and
Prevention (CDC) as a level of concern for children.1,7,9-11
While Pb blood levels in U.S. adults have continuously de-
creased in recent decades (from 13.1 µg/dL in 1976-1980 to
1.6 µg/dL in 1999-2002),12 it is still 2 orders of magnitude
higher than its estimated concentration of 16 ng/dL in prein-
dustrial humans.13 Hg is considered toxic to the kidneys, central
nervous system, cardiovascular, gastrointestinal, and immune
systems.3,14,15 Prenatal exposure to Hg severely affects the
neurobehavioral functioning of offspring.14 Nationally, average
blood Hg levels were reported in childbearing-aged women
(0.92 µg/L) and for children aged 1-5 years (0.33 µg/L), below
the threshold of concern (5.8 µg/L).16
Proteomics is a versatile field of molecular biology dedicated
to the study of the full complement of proteins expressed in
an organism, tissue, body fluid, or cell.17,18 There have been
several proteomic studies that addressed the effects of Pb and
Hg exposure. Heavy exposure of the bacteria K. pneumonia to
Pb caused the decreased expression of DNA gyrase A, as
determined by 2D-PAGE followed by PMF using MALDI-TOF/
MS19 (for the standard proteomic techniques’ abbreviations,
please refer to ref 18). When rat glioma cells were subjected to
prolonged exposure to Pb and analyzed by 2D-PAGE followed
by N-terminal sequencing using Edman’s method, glucose
related protein GRP78 was found to accumulate.20 Using 2D-
PAGE followed by MALDI and ESI-MS/MS sequencing, expo-
sure of rats to Pb acetate resulted in the identification of eleven
proteins with altered expression in kidney cells, notably,
calcium binding proteins, heat shock proteins, and glutathione
S-transferases.21 Rats lens exhibited changes on RA-Crystallin
protein profile upon exposure to Pb, as seen by 2D-PAGE
followed by PMF using MALDI-TOF/MS.22 When rabbits were
exposed to low concentrations of Pb, no myocardial proteins
were identified as significantly associated with Pb concentra-
tions using 2D-PAGE.23 The serum proteome profile was
assessed in humans that were occupationally exposed to
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arsenic and Pb, and five peptides/proteins were found (not
identified) to be significantly up- or down-regulated in exposed
vs unexposed controls using SELDI-TOF on the weak cationic
exchange protein chip.24
With respect to Hg, effects on C. glutamicum were assessed
using 2D-PAGE and MALDI-MS PMF, and six identified pro-
teins responded to Hg, including redox and transport pro-
teins.25 Methylmercury (MeHg) exposure of cultured neurons
from mice caused the decreased expression of 3-ketoacyl-CoA
transferase I, as determined by 2D-PAGE and MALDI-MS
PMF.26 The recent extension of the above pilot work, analyzed
the exposure of the mice neuronal cells to MeHg using better
tools, namely 2D-PAGE, PMF MALDI-TOF and MALDI-TOF/
TOF sequencing. The study identified cofilin’s phosphorylation/
dephosphorylation as a potential mechanism compatible with
the signs of MeHg -induced nerotoxicity.27
To the best of our knowledge, no proteomic studies have
been published on humans with low-level environmental Pb
or Hg exposure. Additionally, there have not been any studies
that have identified proteins related to children’s exposure to
these heavy metals. Previous studies by our group have
established that prenatal (cord) blood Pb levels are associated
with significantly higher baseline systolic blood pressure (SBP)
in nine and a half year-olds.10 In addition, early childhood Pb
levels were associated with a significantly greater total periph-
eral resistance (TPR) response to acute stress.10 It was shown
that family socioeconomic status (SES) is significantly associ-
ated with higher blood Pb levels and SBP, diastolic blood
pressure (DPB), and a TPR response to acute stress, whereas
Pb was found to be mediating the SES-TPR reactivity associa-
tion.9 This proteomic study is meant to enhance the under-
standing of the above findings by exploring the associations
between blood protein levels and subclinical heavy metal
concentrations in a general population of children.
Experimental Section
Participants. Recruitment elicited participation from chil-
dren that: (1) were 9-11 years old, (2) reported no current use
of medication that might affect cardiovascular functioning (e.g.,
Ritalin), and (3) had no significant developmental disorders that
might affect task performance. Participants signed the assent
form while his/her parents signed a consent form; the study
was approved by the Institutional Review Board of SUNY-
Oswego. Blood draws for this study took place at Oswego
Hospital’s draw center located in a family physician’s office.
The first visit took place in February-March of 2005 to measure
blood concentrations of Pb, Hg, glucose, triglycerides, choles-
terol, HDL, and LDL. It was followed within 2 weeks by a 2 h
laboratory visit during which cardiovascular responses to acute
stress were measured9 and additional data (patient’s gender,
education and occupation of parents) were recorded. A second
blood draw took place in October-December of 2006 to
measure the Pb and Hg concentrations again, to collect
sufficient plasma and serum for the proteomic and follow-up
studies, and to assess children’s body mass index (BMI) and
waist to hip ratio.
Trace Metal Concentration Determination. Whole blood
specimens (2 mL) were collected into Vacutainer tubes that
had been precertified by the analyzing laboratory for low-level
measurements of Pb and Hg. Blood specimens were stored at
-80 °C pending shipment to the Trace Elements section of the
Laboratory of Inorganic and Nuclear Chemistry at the New York
State Department of Health’s Wadsworth Center, Albany, NY.
This laboratory is New York State’s principal reference labora-
tory for the measurement of trace metals in blood, as well as
other fluids and tissues, and is responsible for operating the
state’s proficiency testing program for blood metals. The
analyses for Pb and Hg in whole blood were carried out using
a PE Sciex DRC Plus inductively coupled plasma-mass spec-
trometer (PerkinElmer Life and Analytical Sciences, Shelton,
CT).28,29 In brief, 200 µL of whole blood was diluted 1:50 with
a diluent containing nitric acid, Triton X-100, two internal
standards (iridium and rhodium), and gold to control Hg
memory effects.29 Method detection limits (MDL) calculated
from recent data obtained over 20 independent runs were 0.34
µg/dL (2% RSD) for Pb and 0.24 µg/L (5% RSD) for Hg. Given
the lower levels of blood Pb that were expected, the superior
detection limits of ICP-MS were appropriate for this study and
have been used in several biomonitoring studies.28 The instru-
mental signal from each diluted specimen was measured in
triplicate. Four levels of internal quality control materials were
analyzed before, during, and after each run. The method has
been validated against NIST SRM 966 toxic metals in bovine
blood, as well as a new standard reference material (SRM 955c
Pb in caprine blood) that has been certified for Pb and will be
shortly certified for Hg as well.
2D-PAGE. A protease inhibitor cocktail (PIC) containing
AEBSF, aprotinin, bestatin, E-64, leupeptin, and pepstain A
(Sigma Aldrich, St. Louis, MO) was added to 5 mL of patient’s
blood collected in Vacutainers (BD Vacutainer K2, REF 367856),
which contained EDTA (5.4 mg). Samples were centrifuged at
1000× g for 15 min at 4 °C and the resulting plasma was respun
at 2400× g for 10 min at 4 °C to remove any cellular debris.
Plasma was stored in Protein LoBind microcentrifuge tubes
(Brinkmann Instruments Inc., Riverview, FL) at -80 °C until
further analysis. A 20 µL aliquot of initial plasma was depleted
of albumin, IgG, R1-antitrypsin, IgA, IgM, transferrin, hapto-
globin, R1-acid glycoprotein, R2-macroglobulin, apolipoprotein
A-I, apolipoprotein A-II, and fibrinogen using an immunoaf-
finity avian-based IgY spincolumn (Bekman Coulter, Brea, CA).
Depleted samples were further clarified using a ReadyPrep 2-D
cleanup kit (Bio-Rad, Hercules, CA) to remove any remaining
ionic detergents, salts, nucleic acids, and lipids. The pellet was
air-dried for five minutes and rehydrated in 240 µL of 0.5% pH
4-7 carrier ampholyte DeStreak rehydration solution (GE
Healthcare, Piscataway, NJ). The protein concentration was
determined using the Better Bradford Assay kit (Pierce, Rock-
ford, IL) and a KC Junior PowerWave XS microplate reader (Bio-
Tek, Winooski, VT) with a modified protocol to account for any
increases in absorbance due to the presence of DeStreak in
the sample. A 40 µg aliquot of proteins was loaded in three
replicates on 11 cm, pH 4-7, IPG strips (Bio-Rad). Twelve strips
at a time were focused on a PROTEAN IEF instrument (Bio-
Rad) until 35 kVHrs were reached. Focusing wicks were
changed seven times over the first eight hours of focusing to
remove excess salts and any remaining interfering compounds.
After focusing, the strips were treated with dithiothreitol (Bio-
Rad) and iodoacetamide (Bio-Rad). Twelve gels were placed
in a dodecyl SDS-PAGE electrophoresis cell (Bio-Rad) and run
at a constant 200 V for 1 h in a Tris-glycine-SDS buffer at 18
°C. The gels were removed from their casing and fixed in a
solution containing 10%methanol and 7% acetic acid for thirty
minutes. After protein fixing, the gels were placed in ap-
proximately 80 mL of SYPRO Ruby Red dye (Bio-Rad) and
stained overnight. After destaining the gels were scanned using
a Typhoon 9400 fluorescent scanner (GE Healthcare) at a
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resolution of 100 µm. Voltage was varied to allow for maximum
intensity without saturation of signal. Scanned images were
imported into ImageMaster 2D Platinum 5.0 (Amersham Bio-
sciences, Piscataway, NJ) software for analysis. Gels were stored
at 4 °C for future processing. Gel images were cropped to the
same dimensions to allow for accurate percent volume report-
ing of each protein spot. Protein spots were detected using the
following scanning parameters: smoothness, 2; saliency, 15; and
minimum spot area, 25. The gel with the highest number of
paired matches across the top tier and low tier was selected as
the master reference gel. A percent volume protein group report
was generated using the master reference gel and exported for
statistical analysis (see below). Groups that showed a significant
(pe 0.05), or marginally significant (0.05 < p < 0.10) linear trend
across metal tertiles (see below) were manually processed using
the image analysis software and resubmitted for statistical
analysis.30,31 Groups that remained statistically relevant were
then processed for identification. For excision, a depleted,
cleaned preparative sample was manufactured in the same
manner with some minor protocol adjustments. To achieve a
protein load of 500 µg for 2-D gel electrophoresis, multiple post
2-D cleanup samples were pooled and concentrated using
10 000 MW cutoff filters (Brinkmann Instruments Inc.). Two
2-D PAGE gels were stained with Coomassie Brilliant Blue
G-250 (Bio-Rad) dye. Selected groups were excised manually
with brass tubing provided in house with an inner diameter of
1.5 mm and analyzed by both, MALDI-TOF/MS PMF and
LC-MS/MS.
Statistical Analysis. Using SAS software version 9.1.3 service
pack 4, protein spots across all gels (groups) were compared
and ranked to generate an intraclass correlation (ICC) value
to measure variability across a triplicate set of gels.32 Groups
with an ICC value of 0.6 or higher were kept for statistical
evaluation.31,33 This procedure resulted in a set of groups that
could be measured with sufficient reliability to warrant further
analysis. Regression models can be sensitive to outliers due to
the uneven distribution of blood metal levels. In addition, some
participants had Pb or Hg levels below the method detection
limit (MDL), making our data noncontinuous. Both facts
prompted the use of tertiles in our data analysis. Participants
were divided into groups (low, medium, and high) consisting
of approximately equal number of participants based on metal
(Pb and Hg) serum concentration.9,10 General linear modeling
(PROC GLM) was performed for each protein group, testing
the linear trend across tertiles. The confounders were limited
to gender and SES to enhance data interpretation of blood
metal concentration effects on protein expression while avoid-
ing overfitting of data.34-37 Additional analyses considered
blood Pb level (log-transformed) as a continuous variable. Also,
the patients with five highest and lowest Pb concentrations
were compared. The use of tertiles and the log transformation
of data has been used previously in estimating effects of Pb
on the mortality among US adults using the Third National
Health and Nutrition Examination Survey.7
The threshold for significant (p e 0.05), or marginally
significant (0.05 < p < 0.10) associations adopted was not
extremely conservative because the restricted sample size (a
necessity, given the extensive testing using different analytic
approaches) reduces the power to detect associations.38 To
avoid inflating Type II error (not detecting associations), the p
value was not reduced. A too conservative p value might have
been the cause for the lack of findings in the Pb study in
rabbits23 noted in the introduction. We recognize that some
associations may occur by chance (Type I error). To address
this potential error, we have focused only on proteins that show
confirmation using at least two analytical approaches and have
a theoretical justification (see Results and Discussion).
MALDI-TOF/MS PMF and LC-MS/MS of Proteins In-Gel
Pieces. Each gel piece was destained, treated with dithiothrietol,
then iodoacetamide, shrunk by adding acetonitrile, and then
air-dried. To digest proteins, trypsin was added to each gel
piece and incubated overnight in a 30 °C water bath. The
digestion mixture was transferred to a clean 1.5 mL LoBind
tube, centrifuged under vacuum until dry in a vacufuge,
resuspended in 10 µL of a 0.1% trifluoroacetic acid solution,
and concentrated using a Zip-tip (Millipore). The concentrated
samples were then prepared in a 1:1 ratio with R-cyano-4-
hydroxycinnamic acid matrix and analyzed using Autoflex time-
of-flight mass spectrometer (Bruker Daltonik GmbH, Billerica,
MA). Peptide mass to charge (m/z) spectra were collected using
Flexcontrol software version 2.2 (Bruker Daltonik GmbH).
Approximately 800 to 1500 laser shots were collected for each
sample by varying the laser intensity and location on each
target spot. Spectra were imported into Flexanalysis software
version 2.2 (Bruker Daltonik GmbH). Spectra were smoothed
and the baseline was subtracted prior to mass list identification.
Initial mass lists were generated using the automated function
of the software followed by a manual processing to add peaks
not identified by the software. Contamination peaks due to auto
cleavage of trypsin and keratin were removed using a list of
known contaminants and the spectra were imported into the
Biotools software version 2.2 for analysis. Peptidem/z lists were
submitted to the MASCOT probabilistic scoring algorithm
(www.matrixscience.com) for identification. Monoisotopic peaks
were compared against online databases using the following
parameters: database, Swiss-Prot; taxonomy, Homo sapiens;
enzyme, trypsin; allowable missed cleavages, 0; fixed modifica-
tions, carbamidomethyl (C); variable modifications, oxidation
(M); peptide tolerance- 50-150 ppm; mass value, MH+. Peptide
tolerance was increased from 50 ppm until a significant score
was returned from the database search. Upon attainment of a
significant score, identified peaks were documented for internal
calibration use.39 A new m/z list, which included known
contaminants, was generated using Flexanalysis and exported
to Microsoft Excel. Internal calibration was performed by
generating a scatter plot of m/z ratios for contaminants and
known peaks from the initial MASCOT search against experi-
mental values. Calibrated m/z values were generated through
a least-squares method using a second order polynomial fitted
to the data. The known contaminants were deleted from the
calibrated m/z list and the list was exported into the MASCOT
search engine and re-evaluated for significance using the same
search parameters. The mass list was submitted recursively
while lowering the tolerance setting from the initial search until
identified peak deviation remained unchanged at 2σ. This
procedure was performed to eliminate false positive peaks and
improve the overall quality score.39-41
LC-MS/MS was performed at the METACyt Biocehmical
Analysis Center (MBAC) located in the department of Chemistry
at Indiana University, Bloomington, IN. Gel pieces were excised
as described earlier. Samples were placed in a specimen box,
packed in dry ice, and shipped overnight to Bloomington, IN.
Briefly, gel pieces were destained, dried in an Eppendorf
Vacufuge concentrator (Brinkmann Instruments), and digested
with trypsin for 18 h at 37 °C. Trypsin digests were dried in the
Vacufuge concentrator and reconstituted in 10 µL of water. Six
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microliters of trypsin digested samples were separated and
identified using LC-MS/MS as described below. A protein was
reported to be found in a spot only when three or more
sequenced peptides obtained a score at or above the “identity
or extensive homology” score (95% confidence).
LC-MS/MS of Serum Samples. Blood was collected using
Vacutainers (BD Vacutainer K2, REF 367856) and was centri-
fuged at 1000× g for 15 min and the resulting serum was respun
at 2400× g for 10 min at 4 °C to remove any cellular debris.
Serum was stored in Protein LoBind microcentrifuge tubes
(Brinkmann Instruments) at -80 °C until further analysis. One
mL of serum samples (N ) 31) were placed in a specimen box,
packed in dry ice, and shipped overnight to Bloomington, IN.
At MBAC, seven highly abundant proteins (albumin, IgG, IgA,
transferrin, haptoglobin, antitrypsin and fibrinogen) were
depleted using Agilent Multi Affinity Removal System (MARS)
column (4.6 mm ×100 mm, Agilent technologies, Santa Clara,
CA) on an Akta purifier (Amersham Biosciences) using the
manufacturer’s protocol. The depleted sample was collected
and buffer exchanged with 50 mM ammonium bicarbonate and
preconcentrated to ca. 0.5 µg/µL using a 5 kDa MWCO spin
concentrator. After thermal denaturation at 95 °C for 5 min,
samples were reduced through the addition of DTT to a final
concentration of 5 mM and incubated at 60 °C for 45 min.
Alkylation was achieved by adding iodoacetamide to a final
concentration of 20 mM prior to incubation at room temper-
ature for 45 min in the dark. A second aliquot of DTT was then
added, increasing the final concentration of DTT to ca. 10 mM.
The samples were then incubated at room temperature for 30
min to quench the alkylation reaction. Next, trypsin was added
(1:30 w/w) and mixtures were incubated at 37 °C for 18 h. The
enzymatic digestions were finally quenched through the ad-
dition of neat formic acid. The following separation and
identification procedure was used in triplicate for both serum
samples and plasma samples from 2D-PAGE. LC-MS/MS
analyses of the tryptic digests were performed using a Dionex
3000 Ultimate nano-LC system (Dionex, Sunnyvale, CA) inter-
faced to LTQ Orbitrap hybrid mass spectrometer (Thermo
Scientific, San Jose, CA). Prior to separation, a 2 µL aliquot of
trypsin digests (1 µg protein equivalent) was loaded on Pep-
Map300 C18 cartridge (5 µm, 300 Å, Dionex) and eluted through
a pulled-tip capillary column (150 mm × 75 µm i.d) packed
with 90 Å Jupiter C12 bound phase (Phenomenex, Torrance, CA).
Peptides originating from protein tryptic digests were separated
using a reversed-phase gradient from 3-55% of 97% acetonitrile
with 0.1% formic acid over 55 min for proteins isolated from
the human blood, at 300 nL/min flow rate. The mass spec-
trometer was operated in an automated data-dependent mode
that was switching betweenMS scan and CID-MS. In this mode,
eluted LC products undergo an initial full-spectrum MS scan
from m/z 300 to 2000 in the Orbitrap at 15 000 mass resolu-
tions. Subsequently, CID-MS (at 35% normalized collision
energy) was performed in the ion trap. The precursor ion was
isolated using the data-dependent acquisition mode with a 2
m/z isolation width to select automatically and sequentially
five most intense ions (starting with the most intense) in the
survey scan. The total cycle (6 scans) is continuously repeated
for the entire LC-MS run under data-dependent conditions
with dynamic exclusion set to 60 s. Performing MS scanning
in the Orbitrap offers high mass accuracy and accurate charge
state assignment of the selected precursor ions. Mascot version
2.1.3 was used. Data were searched against Homo sapiens
Swiss-Prot database. Trypsin was selected as the enzyme and
one missed cleavage was allowed. A carbomidomethyl was
selected as a fixed modification of all cysteine residues and
acetyl (N-term), oxidation (M), pyro-glu (N-term E) and pyro-
glu (N-term Q) were selected as variable modifications. The
mass tolerance of both MS and MS/MS data was set to 0.8 Da.
Peptides with mass accuracy better than 2 ppm and Mascot
ion score of 30 and above (above the “identity or extensive
homology” score; 95% confidence) were considered as positive
identification. The quantitative analysis of proteins was carried
out using ProteinQuant Suit developed at Indiana University.42
Briefly, the raw data obtained from LTQ-Orbitrap XL mass
spectrometer are converted to MASCOT generic file (MGF).
MGF files were parsed with ProtParser subject to specific
parsing criteria. Minimum MOWSE score was set to 30 and
proteins with 2 peptides match or above were considered as a
confident match. The peptide mass threshold, peak width and
apex assignment window were set to 600 Da, 1.0 and 0.5 min,
respectively. Then, all parsed files were combined into a master
file that contains the list of all proteins and peptides identified
in all the processed LC-MS/MS analyses. Then the combined
master files incorporated with their corresponding mzXML files
were submitted to ProteinQuant as described previously.42 Two
separate sets of data (runs for 10 patients and for 22 patients)
were merged by removing proteins that were not found in any
one set and renormalizing all data.
Western Blot for Apolipoprotein E. An 11% SDS-PAGE gel
was run with 0.2-1.0 mg of total proteins from PIC-treated
plasma for a single patient to establish the linearity and the
specificity of the response. Then, 0.5 mg of proteins of PIC-
treated patients’ plasma was loaded in triplicate onto nitrocel-
lulose membrane using the slot-blot Bio-Dot SF Microfiltration
Apparatus (Bio-Rad). Each blot was also loaded with an internal
standard at two different concentrations in triplicate. The
membrane was blocked by incubating in 25 mL of blocking
solution (5% dried milk in TTBS, 0.1% Tween-20 in Tris-
buffered saline pH 7.4) at room temperature for 1 h. The
membrane was incubated with a primary monoclonal anti-
ApoE antibody ab1906 (Abcam, Cambridge, MA) 1:5000 in a
blocking solution for 1-3 h at room temperature, rinsed six
times with TTBS, incubated with a secondary goat poly clonal
antimouse IgG (conjugated to horseradish peroxidase) 1:25 000
in blocking solution for 1 h, and then rinsed with TTBS six more
times. The membrane was immediately used for film exposure.
Chemiluminescense was achieved with the SuperSignal West
Pico Chemiluminescent Substrate Kit (Pierce). Developed film
was scanned using ImageScanner UTA-110 with compatible
software, LabScan 5.0 1.0.8 (Amersham Biosciences). Each
image was converted to a 300 dpi TIF file and exported to
ImageQuant 5.0 (Molecular Dynamics). Identically sized boxes
were placed around each exposed band and analyzed for
exposure density with background correction.
In general, HUPO PPP guidelines were consulted,43 and most
sensitive techniques and most rigorous protocols available to
us were used. Detailed protocols are available in the Supporting
Information. The outline of proteomic work is summarized in
Figure 1.
Results and Discussion
Participants. The population of children in this study (N )
34) had approximately equal number of both genders, and was
predominantly Caucasian. These factors along with their body
mass index and the measure of the socioeconomic status (Four
research articles Birdsall et al.
4446 Journal of Proteome Research • Vol. 9, No. 9, 2010
Factor Index of Social Status according to Hollingshead44) were
typical for children in this area9,10,45 (see Table 1).
Pb and Hg concentrations were measured in triplicate at two
different times. When available (N ) 28), averages of two
measurements were used to get a better estimate of the long-
term value of exposure to environmental toxicants. Mean Pb
concentrations were found to be several-fold lower as com-
pared to a previous study in this area (0.99 vs 4.62 µg/dL10).
The concentration was about 60% less than that of the national
mean among adults in 1999-2002.12 The average Pb concen-
tration of 0.99 µg/dL, while well below the 10 µg/dL limit, is in
the range that may be relevant to both children and adult
health.7,10 Hg blood concentrations are harder to evaluate.
Concentrations we found were below the 5.8 µg/L limit of
concern, and the average (0.72 µg/L) was about twice the
national average found in 1-5 year old children (0.33 µg/L)
and close to the national average in child bearing women (0.92
µg/L).46 We are unaware of any publications on Hg blood
concentrations in this area or the medical relevance of such
low blood Hg concentrations to human health.
2D-PAGE. The average protein concentration in PIC-treated
plasma samples was determined to be 74 ( 8 µg/µL, which
was within the literature range of 62-100 µg/µL.47,48 Each
patient’s sample was depleted of the twelve most abundant
proteins, which, as expected, removed about 93% of all
proteins. To overcome the migratory variability of proteins in
gels that arise from different running conditions, gels were run
twelve at a time, four patients in triplicate, in a dodecyl cell at
constant voltage, time, and temperature.49 All 102 gels were
digitized using a fluorescent scanner. The depletion, large size
gels, and the use of fluorescent SYPRO Ruby Red allowed for
the detection of a large number of distinct protein groups, with
an average of 1377 and up to 1544 per gel. A single gel (patient
26, run 3) was selected as a reference gel based on a number
of protein spots detected, resolution, minimum artifacts, and
ability to generate significant number of groups across all gels.
Groups (1286 in all) were identified across all gels with an
average 86% RSD within triplicates (across all proteins for
patient 26) in the raw data. During statistical analysis with SAS,
870 groups were eliminated as not passing the intraclass
correlation (ICC) cutoff value of 0.6, eliminating most of the
inconsistent triplicates. The remaining 416 groups (48% RSD,
across all proteins for patient 26) were analyzed for associations
with Pb or Hg tertiles. Pb tertiles were 0.27-0.74 µg/dL (11
patients), 0.74-0.978 µg/dL (12 patients), and 0.978-3.16 µg/
dL (11 patients). Hg tertiles were 0.13-0.38 µg/L (11 patients)
0.38-0.75 µg/L (12 patients), and 0.75-4.36 µg/L (11 patients).
While 48 groups were initially found to be associated with Pb
or Hg, only 13 manually processed groups exhibited either
significant (p e 0.05) or marginally significant (0.05 < p < 0.10)
volume association with Pb tertiles and 11 with Hg tertiles
(Figure 2).
Gender and SES were used as covariates for all statistical
analyses. Twenty-two out of twenty-four groups were success-
fully identified with PMF using MALDI-TOF/MS with the
MOWSE score from the SwissProt database being higher than
55 and average mass accuracy of 18 ppm (see Supporting
Information). Since the concentration of proteins was insuf-
ficient to confirm this identification using PSD on the MALDI-
TOF/MS using even 500 µg of protein per gel, samples were
reanalyzed using LC-MS/MS on an LTQ OrbiTrap mass spec-
trometer to accommodate HUPO PPP requirements.43 Data was
filtered from the master list of ninety-four proteins identified
using total percent intensity (>15%), mass accuracy (exceeding
2 ppm), sequenced queries matched (less than two), mis-
matches between PMF and de novo sequence identities,
contaminants, depleted proteins, and molecular weight. The
combined set of unequivocally identified groups (5 for Pb and
5 for Hg) is presented in Table 2. For Pb tertiles, two groups of
apolipoprotein E, clusterin, chain C human complement
component C3c, and vitronectin were found statistically sig-
nificant or marginally significant. N-Acetylmuramoyl-L-alanine
amidase, complement factor H-related protein 2, two groups
of gelsolin, and vitronectin were associated with Hg. For groups
that were identified using both methods, an average RSD for
proteins triplicates across all patients was 26%. While it is very
advantageous and sometimes necessary to see different iso-
Figure 1. General outline of proteomic studies of a general
population of children exposed to low levels of environmental
lead and mercury. Plasma proteins were separated by 2D-PAGE
in triplicate and proteins were identified by PMF with MALDI-
TOF/MS as well as by LC-MS/MS. Serum proteins were digested
with trypsin and peptides were separated and analyzed using
LC-MS/MS in triplicate.
Table 1. Characteristics of Participants
Number of children 34
Gender (male) 47%
Race (Caucasian) 94%
average SD min max
Age (First Analysis) 10.59 1.09 6.96 12.04
Age (Second Analysis) 12.24 1.13 8.61 13.72
Socioeconomic Status 40.44 10.01 12.00 64.50
Body Mass Index, kg/m2 20.33 4.08 12.73 30.85
Lead, microgram/dL 0.99 0.54 0.27 3.16
Mercury, microgram/L 0.72 0.73 0.13 4.36
Figure 2. 2-D map of significant protein groups. Representative
2-D polyacrylamide gel prepared with 40.0 µg of protein followed
by staining with SYPRO Ruby. Twenty-four protein groups that
associated with Pb or Hg tertiles are indicated by arrows.
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forms and post-translational modifications of proteins using
2D-PAGE, the relatively large RSD in quantification of proteins
made 2D-PAGE only partially useful in our case since an
average observed up- or down-regulation across identified
proteins was only 39%. Among the proteins in Table 2, two
should be noted for a significant association with metal tertiles
(p e 0.05) and a significantly smaller RSD as compared to the
corresponding regulation value. For Pb, that is apolipoprotein
E (group 7019), and for Hg, that is gelsolin (group 6371).
To further validate our study, 32 serum samples of the
original thirty-four patient samples were subjected to LC-MS/
MS. Since this analysis starts with protease digestion, and
inhibitors present in PIC-treated plasma would impede trypsin,
serum samples were used instead. Serum was not available for
the LC-MS/MS analysis of two patients. One patient had very
inconsistent data (10-fold higher RSD than other samples), and
was excluded as well. The overall RSD within triplicate LC runs
across all proteins for patient 26, which was used as the
reference in 2D-PAGE studies, was 3.1%; almost an order of
magnitude less than that in 2D-PAGE. Pb tertiles were 0.27-0.70
µg/dL (10 patients), 0.70-0.975 µg/dL (11 patients), and
0.975-3.16 µg/dL (10 patients). Hg tertiles were 0.13-0.35 µg/L
(10 patients), 0.35-0.75 µg/L (11 patients), and 0.75-4.36 µg/L
(10 patients). Proteins were identified with better than 2 ppm
mass accuracy and a minimum of two peptides sequenced
across all patients. Quantification reports consisting of 94
unequivocally identified proteins from 31 serum samples were
generated according to the percent of total peak area intensity
represented in the chromatogram for those peaks that were
present in all samples. General linear modeling with an ICC
cutoff value of 0.6 to identify significant regulation across
tertiles controlling for gender and socioeconomic status using
SAS did not exclude any proteins from this list. Sixteen proteins,
4 for Pb and 12 for Hg, were identified as having significant (p
e 0.05) or marginally significant (0.05 < p < 0.10) associations
with metal tertiles (Table 3). Among the proteins identified, an
average RSD for proteins triplicates across all patients was 7%,
while an average observed up- or down-regulation across
identified proteins was 44%. Since the precision and accuracy
were significantly better in LC data as compared to 2D-PAGE
data, we will further discuss the relevance of proteins identified
with LC-MS/MS.
LC-MS/MS Data with Respect to Blood Pb Concentration.
Apolipoprotein E (ApoE) was identified as a protein exhibiting
a significant association (p < 0.005) of negative 31% in volume
across Pb tertiles with an RSD of 3%. Notably, ApoE was the
only protein identified by 2D-PAGE analysis as well (p e 0.05,
49% down-regulation, 15% RSD). For that reason, additional
statistical evaluations of this linear trend were made. When the
top five Pb concentration and bottom five Pb concentration
patients were considered from LC-MS/MS data, ApoE was
found to be down by 39%. In addition, the Pb concentrations
were log transformed and the linear relationship was confirmed
from LC-MS/MS data for ApoE across all 31 patients as
significant (controlling for SES and gender all studies; pe 0.05).
Finally, Western blot was performed using monoclonal anti-
ApoE antibody for plasma-PIC samples (N ) 34). ApoE was
found to be significantly associated with Pb tertiles as well (p
e 0.05, 34% down-regulation, 20% RSD). Western blot had an
RSD comparable to that of 2D-PAGE. Western’s strong advan-
tage was in its ability to discriminate against all other proteins,
as ApoE was the only protein detected on the gel. ApoE’s
concentration was linear with the chemoluminescent signal
produced. This particular antibody could not discriminate
among different forms of ApoE, just like LC-MS/MS, while 2D-
PAGE could. Different ApoE detection methods are summarized
in Figure 3.
ApoE is a member of a family of proteins known as
apolipoproteins, which in part regulate lipid transport in the
body, specifically, low-density lipoproteins (LDL).50 ApoE binds
to LDL receptors along the lipid bilayer and facilitates the
transport of fats.50 Humans have three variants of the ApoE
gene, 2 (with two Cys in protein’s structure), 3 (with one Cys
and one Arg), and 4 (with two Arg), which can make six
possible phenotypes.51 In humans, ApoE genotyping provides
modest positive associations with plaque and coronary heart
disease outcomes.51 This is important because it has been
established that current blood Pb levels in children were
associated with greater TPR and stroke volume (SV) responses
to acute stress, parameters that may lead to cardiovascular
disease.10 The TRP and SV associations with lead tertiles were
Table 2. Plasma Proteins Associated with Pb and Hg Concentrations, Quantified from 2D-PAGE Data and Identified with
MALDI-TOF/MS and LC-MS/MSa
2D page data MALDI-TOF/MS LC-MS/MS
metal group Swiss-Prot # protein ID
SAS









Pb 7019 P02649 Apolipoprotein E 0.0268 -49.17 14.64 178 144 18 52 793 14 59
6973 P10909 Clusterin 0.0868 -18.63 10.6 112 87 8 24 401 9 26
6903 P01024 Chain C, Human Complement
Component C3c
0.0954 27.07 18.39 137 5 14 46 1346 24 21
6418 P04004 Vitronectin 0.0955 32.82 11.58 119 78 12 26 495 9 25
7003 P02649 Apolipoprotein E 0.0976 44.53 35.26 117 88 12 36 74 2 13
Hg 6491 Q96PD5 N-acetylmuramoyl-L-alanine
amidase
0.0182 69.48 53.7 114 84 12 28 407 7 19
7029 P36980 Complement factor H-related
protein 2
0.0236 -43.76 34.76 98 59 10 30 220 4 18
6371 P06396 Gelsolin 0.0454 -21.22 9.57 93 63 12 23 602 11 22
6530 P04004 Vitronectin 0.0472 -59.46 61.51 82 61 8 18 368 6 19
6369 P06396 Gelsolin 0.0568 -19.99 10.68 176 139 19 33 303 5 9
a Swiss-Prot # is the protein accession number, SAS p value is the significance of the association across tertiles, regulation is a percentage increase or
decrease of the protein volume across tertiles, RSD is a relative standard deviation, calculated as standard deviation/average × 100% within triplicates
across all patients, Sm is the MOWSE score or the sum of the MOWSE scores for all queries, ∆Sm is the difference in MOWSE scores of the identified
protein and the next closest match, matched peaks is the number of peaks identified in the PMF, queries matched is the number of sequenced peptides
identified by LC-MS/MS, and sequence coverage is the percentage of residues covered by the identified peaks.
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also observed in this study (data not shown), and we also found
an association of Pb with ApoE. Most significantly, there is
evidence that Pb exposure affects psychiatric symptoms in
adults.52 Moreover, neurobehavioral changes (executive ability,
manual dexterity, psychomotor skills) due to Pb exposure have
been associated with ApoE 4 allele.53 There is a presumed
protective role of ApoE 2 and 3 in Pb53 and Hg54 toxicity for
adults. When compared to 4, these two genotypes are more
frequent in a population, proteins are expressed more, have
more Cys, and are capable of forming dimers.55-57 Interest-
ingly, in children, it is ApoE 4 that protects them better than
ApoE 2 or ApoE 3; among 311 subjects, the negative effects
for umbilical cord Pb level on the Mental Development Index
of the Baley Scale was almost 4-fold greater among ApoE 2/3
carriers.58 Neither of these two studies measured the levels of
ApoE, and this is the first report to highlight the relationship
between low-level Pb and ApoE in children. Unfortunately, lack
of sample prohibits us from genotyping this cohort of subjects.
On the basis of our studies in children with the environmental
exposure to Pb, we cannot say whether Pb affects apoE levels
or apoE affects Pb. To address these issues, the expanded
studies with Pb and ApoE measurements, ApoE genotyping,
and experiments designed to define the directionality of the
relationship are underway in our laboratory.
In addition to ApoE, three more potential cardiovascular
disease related proteins were identified (0.05 < p < 0.10). These
include haptoglobin, which is an inflammatory response protein
associated with CVD such as atherosclerosis59-61 coagulation
factor XII, which is a cascade protein associated with coronary
heart disease and increased artherosclerotic burden62-64 and
complement component C9, which is an autoimmune response
protein associated with inflammation.65-68 These proteins should
not be overlooked as participants in cardiovascular disease since
a composite index of weakly associated factors can act as an
indicator for disease progression.30,69
Table 3. Serum Proteins Associated with Pb and Hg Concentrations, Quantified and Identified by LC-MS/MSa
metal protein ID Swiss-Prot #
SAS
p-value regulation, % RSD, % Sm queries used in quantification
sequence
coverage, %
Pb Apolipoprotein E P02649 0.0046 -30.87 2.88 688 8 37
Haptoglobin P00738 0.082 55.02 1.46 1195 18 54
Coagulation factor XII P00748 0.0842 18 11.97 144 2 4
Complement component C9 P02748 0.0935 28.98 9.63 212 3 10
Hg Peptidase inhibitor 16 Q6UXB8 0.0031 -32.11 6.79 68 RPYQEGTPCSQCPSGYHCK 4
Complement component C7 P10643 0.0069 -38.75 6.44 104 2 5
Pigment epithelium-derived factor P36955 0.0165 49.88 15.14 139 2 12
Insulin-like growth factor-binding
protein complex acid labile chain
P35858 0.0232 -17.59 5.79 83 2 6
Complement factor I P05156 0.0324 23.31 3.98 143 2 4
Apolipoprotein D P05090 0.0487 -33.74 5.47 88 MTVTDQVNCPK 6
Ig mu related P04220/P01871 0.0501 293.01 12.46 598/765 10/12 38/36
Interalpha-trypsin inhibitor
heavy chain H3
Q06033 0.0515 -26.52 6.97 57 LWAYLTIEQLLEK 2
Alpha-1-acid glycoprotein 2 P19652 0.0651 16.34 2.75 300 4 26
Thyroid receptor-interacting
protein 11
Q15643 0.0707 25.68 12.32 72 2 2
Gelsolin P06396 0.0767 -12.07 2.21 526 8 20
Alpha-2-macroglobulin P01023 0.0979 -8.86 0.54 4792 76 66
a Swiss-Prot # is the protein accession number, SAS p value is the significance of the association across tertiles, regulation is a percentage increase or
decrease of the protein volume across tertiles, RSD is a relative standard deviation, calculated as standard deviation/average*100% within triplicates across
all patients, Sm is the sum of the MOWSE scores for all queries, Queries used in quantification is the number of LC peaks identified across all runs that
was used to quantify the amount of protein, and sequence coverage is the percentage of residues covered by the peaks listed.
Figure 3. Concentration of Apolipoprotein E across Pb tertiles using different detection methods. Groups 7014, 7019, 7003 on 2D-PAGE
were identified as significantly associated with Pb tertiles, identified by PMF only; the sum of % protein intensities are added for PMF
only bars; 7019 and 7003 were confirmed by LC-MS/MS, the sum of those two groups is shown in PMF+MS/MS bars; LC-MS/MS
percent intensity of ApoE concentration was multiplied by 10 to fit the scale of the graph; Western blot units of ApoE concentration
were multiplied by 10-9 to fit the scale of the graph.
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Interestingly, ApoE and Pb have each been implicated in
Alzheimer’s disease (AD). The ApoE 4 allele has been shown
to play a role in AD,70 and exposure to Pb early in life induces
AD-like pathology in aging rats71,72 and monkeys.73 Studies in
adults with and without AD found that serum concentrations
of ApoE are decreased in AD patients; however, those concen-
trations were not as useful a marker for AD as the presence of
the 4 allele.55,74,75 While AD is beyond the scope of this study,
the above is in general agreement with our observations of the
inverse association between Pb and ApoE serum concentrations.
LC-MS/MS Data with Respect to Blood Hg Concentration.
The search for proteins that exhibited expressional difference
with respect to Hg produced some relevant results. Peptidase
inhibitor 16, complement component C7, pigment epithelium-
derived factor, insulin-like growth factor-binding protein com-
plex acid labile chain, complement factor I, and apolipoprotein
D were identified as proteins exhibiting significant volume
regulations (p e 0.05) across Hg tertiles. Complement compo-
nent C7 and complement factor I are inflammatory response
proteins.66,76-78 Apolipoprotein D has been identified as a
protein involved in lipid ransport.79 Pigment epithelium derived
factor protein and insulin-like growth factor-binding protein
have been associated with vascular injury and heart failure,
respectively.80,81 In addition to these proteins, four of the six
marginally significant proteins (Table 3, 0.05 < p < 0.1) were
characterized as proteins with cardiovascular roles. Immuno-
globulin mu heavy chain disease protein, interalpha-trypsin
inhibitor heavy chain H3, alpha-1-acid glycoprotein 2, thyroid
receptor-interacting protein 11, gelsolin, and alpha-2-macro-
globulin were identified as exhibiting marginally significant
regulations across tertiles. Interalpha-trypsin inhibitor heavy
chain H3, gelsolin, and alpha-1-acid glycoprotein 2 were
identified as inflammatory sensitive proteins associated with
myocardial infarction and heart failure.82-86 In addition to this,
gelsolin has been identified as being down-regulated by gel
electrophoresis followed by MALDI-TOF/MS and tandemmass
spectrometry. Alpha-2-macroglobulin, a protease inhibitor, has
been associated with the progression of cardiac disease.87
Peptidase inhibitor 16 (PI16), Ig mu heavy chain disease
protein, and thyroid receptor-interacting protein 11, were not
readily identified through literature searches as having a known
role in cardiovascular disease. The importance of these as-
sociations should not be overlooked despite the facts that at
the blood concentrations of Hg in our patients, which are
relatively low, no apparent effects on humans are known14 and
none of these proteins are known to us as being involved in
Hg-induced problems; this data might be useful in developing
biological markers of metal toxicity later on.88
Experimental Limitations. Limitations of the current study
should be considered for future toxicological proteomic studies.
The current sample size is insufficient to provide the breadth
needed to statistically evaluate a complete model of Pb and
Hg as predictors of cardiovascular functioning. The small size
of our study cohort can only support the use of two confound-
ers (SES and gender) without overfitting the data resulting in
a biased analysis. Similarly, a new larger sample size study
would also allow us to consider the potential interaction
between Pb and Hg and the potential association of ApoE
genotype with concentrations of metals or cardiovascular
parameters in our patients. Also, larger size of the sample might
improve or disprove the significance of the associations we
have so far identified.38
Further limitations imposed on us by our current sample are
the racial composition (94% Caucasian) and the metal concentra-
tion distribution (relatively low) in our patients. While both were
typical for the local population, they limit our ability to extrapolate
our findings to the population across the U.S., and we also cannot
extrapolate our findings to any other concentrations of heavy
metals but the ones we have measured.
Shot-gun proteomics of human blood, a very complex system
with a multitude of proteins present, may provide us with some
associations that are not true. On the other hand, despite the
increased sensitivity of the LC-MS/MS method used, only a
fraction (94 proteins) of a conservative estimate of one thou-
sand detectable proteins was identified in our study. Even if
all these proteins were relevant to cardiovascular disease risk,
this would only represent half of the previously identified
cardiovascular proteins.30 It is evident that technological
advancements are still needed for a complete understanding
of the human proteome.
Lastly, our cross-sectional approach does not allow us to
determine the causal pathway explaining the association
between metal levels and protein levels in our patients.
Conclusions
The present study demonstrates the vital role proteomics has
in toxicological studies. We found that 2D-PAGE, LC-MS/MS,
and Western blot had different strengths and weaknesses, and
complimented each other and thereby provided a more
complete picture of the associations being considered. We
successfully identified 16 proteins in children’s blood that
exhibited associations in the presence of low-level concentra-
tions of Pb and Hg using LC-MS/MS. Of the 16 proteins
identified, 13 were associated with cardiovascular disease, 7
of which were significantly up- or down-regulated in the
presence of Pb and Hg. These findings support previous
evidence that have associated Pb and Hg exposure with an
increase in risk factors related to cardiovascular disease such
as elevated blood pressure and heightened vascular response
to acute stress.10,78,89 Of the 7 significantly regulated proteins,
ApoE was identified as being significantly regulated through
three alternative methods of detection and analysis, gel elec-
trophoresis, liquid chromatography, and Western blot, thus
validating it for further assessment as a biomarker of CVD
related to blood Pb levels in children.35 ApoE polymorphisms
influence plasma concentrations of total cholesterol, LDL
cholesterol, ApoB, concentration of ApoE, confer a greater risk
of coronary heart disease and, importantly, influence the risk
of injury by Pb.51,53,58 This proteomic study has shown a
statistically relevant association of ApoE with Pb in children’s
blood at levels that are well below the threshold of concern
established by the CDC. The health risk to adults and children
posed by persistent environmental toxicants such as heavy
metals validates the need to extend the current proteomic study
to further explore the relationship between ApoE and Pb
toxicity.
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